Perimenopausal Transdermal Estradiol Replacement Reduces Serum HDL Cholesterol Efflux Capacity but Improves Cardiovascular Risk Factors

BACKGROUND: The cardiovascular (CV) safety of estrogen replacement therapy (ERT) in perimenopausal women remains uncertain. Although exogenous estrogens increase HDL cholesterol (HDL-C), estrogen-mediated effects on alternative metrics of HDL that may better predict CV risk are unknown. OBJECTIVE: T...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Clin Lipidol
Egile Nagusiak: Vaisar, Tomas, Gordon, Jennifer L, Wimberger, Jake, Heinecke, Jay W, Hinderliter, Alan L, Rubinow, David R, Girdler, Susan S, Rubinow, Katya B
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7887026/
https://ncbi.nlm.nih.gov/pubmed/33288437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacl.2020.11.009
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak